πŸ•΅οΈ Genworth Financial Inc ($GNW)

SEC insider & ownership activity, last 12 months Β· CIK 1276520 Β· every row links its SEC filing

Over the last 12 months insiders sold $3.7M with no open-market buying against it. Thomas J. McInerney sold $2.3M in discretionary trades (Dec–Sep). No red-flag 8-Ks in the window.

Oct 2025: net +$0 Nov 2025: net -$340K Dec 2025: net -$346K Jan 2026: net +$0 Feb 2026: net +$0 Mar 2026: net +$0 Apr 2026: net +$0 May 2026: net -$1.4M Jun 2026: net +$0 Jul 2026: net +$0 Aug 2026: net -$542K Sep 2026: net -$1.1M
Monthly net open-market insider flow, last 12 months (up = net buying)

Insider flow

0 buyers, $0 (0 lots) Β· 4 sellers, $3.7M (7 lots)

InsiderBuysBoughtSellsSoldLast
Thomas J. McInerney0– 3$2.3MSep 3, 2026
Gregory S. Karawan0– 2$737KAug 21, 2026
Robert P. Restrepo Jr.0– 1$456KMay 22, 2026
Hagerman Melissa0– 1$146KAug 24, 2026

5%+ holders

HolderStakeClassScheduleEvent
Vanguard Portfolio Management 6.1% 13GApr 29, 2026 filing β†—
Donald Smith & Co., Inc. 5.9% 13GAug 11, 2026 filing β†—
DSCO Value Fund, L.P. 5.9% 13GAug 11, 2026 filing β†—
Vanguard Capital Management 5.4% 13GApr 29, 2026 filing β†—

Planned insider sales (Form 144)

SellerPlannedApprox. sale date
Thomas J. McInerney$1.1MSep 3, 2026 filing β†—
Hagerman Melissa$146KAug 24, 2026 filing β†—
Gregory S. Karawan$396KAug 21, 2026 filing β†—
Robert P. Restrepo Jr.$456KMay 22, 2026 filing β†—
Thomas J. McInerney$927KMay 22, 2026 filing β†—
Thomas J. McInerney$346KDec 2, 2025 filing β†—
Gregory S. Karawan$340KNov 24, 2025 filing β†—

Material events (8-K)

ItemEvent date
Officer/director changes (5.02)Aug 20, 2026 filing β†—
Earnings (2.02)Aug 5, 2026 filing β†—
Financial Statements and Exhibits (9.01)Aug 5, 2026 filing β†—
Officer/director changes (5.02)Jul 7, 2026 filing β†—
Shareholder vote (5.07)May 20, 2026 filing β†—
Earnings (2.02)May 5, 2026 filing β†—
Financial Statements and Exhibits (9.01)May 5, 2026 filing β†—
Earnings (2.02)Feb 23, 2026 filing β†—
Financial Statements and Exhibits (9.01)Feb 23, 2026 filing β†—
Earnings (2.02)Feb 3, 2026 filing β†—
Financial Statements and Exhibits (9.01)Feb 3, 2026 filing β†—
Earnings (2.02)Nov 5, 2025 filing β†—
Financial Statements and Exhibits (9.01)Nov 5, 2025 filing β†—